EUVIMEDEUVIMED entdecken
Open Access

Controlling viral inflammatory lesions by inhibiting fatty acid metabolism

Engin Berber, Barry T Rouse

Microbes and Infection · 2023

DOI: 10.1016/j.micinf.2023.105141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbes and Infection, 2023. Verfasst von Engin Berber und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee Knoxville, TN, 37996, USA. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Herpes Simplex, Encephalitis, Keratitis, Herpetic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herpes simplex virus infection is a major cause of vision loss in humans. Eye damaging consequences are often driven by inflammatory cells as a result of an immune response to the virus. In the present report, we have compared the effect of inhibiting energy metabolism with etomoxir (Etox), which acts on the fatty acid oxidation pathway and 2-Deoxy-d-glucose (2DG), which acts on glycolysis for their inhibitory effects on herpetic ocular lesions. Both drugs showed similar protective effects when therapy was started on the day of infection, but some 2DG recipients succumbed to encephalitis. In contrast, all Etox recipients remained healthy. Both drugs were compared for effects on inflammatory reactions in the trigeminal ganglion (TG), where virus replicates and then establishes latency. Results indicate that 2DG significantly reduced CD8 and CD4 Th1 T cells in the TG, whereas Etox had minimal or no effect on such cells, perhaps explaining why encephalitis occurred only in 2DG recipients. Unlike treatment with 2DG, Etox therapy was largely ineffective when started at the time of lesion expression. Reasons for the differential effects were discussed as was the relevance of combining metabolic reprogramming approaches to combat viral inflammatory lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 1, HumanHerpes SimplexEncephalitisKeratitis, HerpeticHumansCD4-Positive T-LymphocytesFatty AcidsCD8-Positive T-LymphocytesVirus Latency

Stichwörter der Autor:innen

2DGEtomoxirFAOHSVImmunometabolismImmunopathogenesis

Substanzen

Fatty Acids

Autor:innen und Institutionen

  • Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee Knoxville, TN, 37996, USA.
  • Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee Knoxville, TN, 37996, USA. Electronic address: btr@utk.edu.

Förderung

  • NEI NIH HHS
  • National Institutes of Health

Zitieren

APA

Berber, E., & Rouse, B. T. (2023). Controlling viral inflammatory lesions by inhibiting fatty acid metabolism. Microbes and Infection. https://doi.org/10.1016/j.micinf.2023.105141

Vancouver

Berber E, Rouse BT. Controlling viral inflammatory lesions by inhibiting fatty acid metabolism. Microbes and Infection. 2023. doi:10.1016/j.micinf.2023.105141

BibTeX
@article{Berber2023,
  author = {Berber, Engin and Rouse, Barry T},
  title = {Controlling viral inflammatory lesions by inhibiting fatty acid metabolism},
  journal = {Microbes and Infection},
  year = {2023},
  doi = {10.1016/j.micinf.2023.105141}
}
Kostenlos starten →